The U.S. Oncology business within our company is a growing and dynamic part of our company. We have an exciting opportunity to join our dynamic marketing team focusing on intismeran autogene, a cutting-edge individualized neoantigen therapy (INT), which represents a transformative approach to cancer treatment, as part of our alliance partnership. We are seeking a Director, US Oncology Marketing, INT Treatment Site Strategy & Execution Lead . This role will be pivotal in the development and execution of innovative strategic commercial plans to support the seamless end-to-end patient journey for intismeran autogene. This process begins with the acquisition of patient tumor and blood samples, genetic sequencing of the samples, customized manufacturing of the individualized therapy and subsequent delivery back to the health care provider for administration to the patient in combination with our immuno-oncology product. This role will also drive the strategy to develop the treatment site network and site readiness for the launch of intismeran autogene. This position will report to the Executive Director, U.S. Oncology Marketing, Intismeran Autogene/Alliance Lead and work cross-functionally with multiple teams across the organization to support the launch of this innovative therapy.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director
Number of Employees
5,001-10,000 employees